Al's Comment:

 Orbus Therapeutics launched a new website for their clinical trial of oral Eflornithine (plus lomustine vs. lomustine alone).

 

Disclaimer: Orbus Therapeutics is a sponsor of the Musella Foundation.


Posted on: 08/27/2017

STELLAR trial for Recurrent Anaplastic Astrocytoma 

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!